Answers are grounded in this paper and cite their sources.
The optimal antiplatelet strategy after coronary artery bypass graft (CABG) surgery in patients with chronic coronary syndromes (CCS) is unclear.
No takes yet. Share an insight, caveat, or question.
Sandner et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: